Alzheimer'S Disease Clinical Trials in Houston, TX

Alzheimer'S Disease Clinical Trials in Houston, TX

View the best 10 alzheimer's disease medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Alzheimer'S Disease clinical trial.

Trials in Houston, Texas

Here are the top 8 medical studies for alzheimer's disease in Houston, Texas

Image of Local Institution - 0001 in Tampa, United States.

BMS-986368

FAAH/MGLL inhibitor

Recruiting0 awardsPhase 2
This trial is testing a new drug called BMS-986368 to see if it is effective, safe, and well-tolerated in treating agitation in people with Alzheimer's Disease.
Image of Houston Methodist Research Institute in Houston, United States.

11C-ER176

Cytokine Therapy

Recruiting0 awardsPhase 2
This trial will investigate how inflammation in the body and brain can be measured using blood and cerebrospinal fluid biomarkers. The study will also look at how a low dose of interleukin-
Image of The University of Texas Health Science Center at Houston (UTHealth) in Houston, United States.

Choline

Dietary Supplement

Recruiting1 awardPhase 1
This trial tests if choline bitartrate, a dietary supplement, can help people at risk of Alzheimer's Disease. The supplement aims to improve how brain cells handle fats, potentially keeping them healthy and functioning properly.
Image of Location - 001 in Princeton, United States.

KarXT

Behavioural Intervention

Recruiting1 awardPhase 3
This trial aims to test the safety and effectiveness of KarXT in adults with Alzheimer's Disease who also have psychosis.
Image of Noah Clinical Site 017 in Scottsdale, United States.

Polypill

Fixed Dose Combination

Recruiting0 awardsPhase 2
This trial aims to see how well a combination drug called a polypill works for patients with Alzheimer's Disease over 180 days. They will include male and female patients aged 50-85 with
Image of Clinical Research Site in Birmingham, United States.

AVP-786

Behavioural Intervention

Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of Banner Alzheimer's Institute- Clinical Trials Department in Phoenix, United States.

ACU193

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial aims to test if ACU193 infusions given every four weeks can help slow down mental and physical decline in people with early Alzheimer's disease compared to a placebo.
Image of ARS- Neurology and Neurodiagnostics of Alabama in Hoover, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.